Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP492072.RARhLtFJU3RcUztEO-Iyy1gaHW_UHEmW0fdaMpEmOZM4Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP492072.RARhLtFJU3RcUztEO-Iyy1gaHW_UHEmW0fdaMpEmOZM4Q130_assertion type Assertion NP492072.RARhLtFJU3RcUztEO-Iyy1gaHW_UHEmW0fdaMpEmOZM4Q130_head.
- NP492072.RARhLtFJU3RcUztEO-Iyy1gaHW_UHEmW0fdaMpEmOZM4Q130_assertion description "[We evaluated the effects of different doses of interleukin-2 (IL-2)-transduced fibroblasts in the treatment of colorectal carcinoma in the CT-26 murine tumor model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492072.RARhLtFJU3RcUztEO-Iyy1gaHW_UHEmW0fdaMpEmOZM4Q130_provenance.
- NP492072.RARhLtFJU3RcUztEO-Iyy1gaHW_UHEmW0fdaMpEmOZM4Q130_assertion evidence source_evidence_literature NP492072.RARhLtFJU3RcUztEO-Iyy1gaHW_UHEmW0fdaMpEmOZM4Q130_provenance.
- NP492072.RARhLtFJU3RcUztEO-Iyy1gaHW_UHEmW0fdaMpEmOZM4Q130_assertion SIO_000772 7578396 NP492072.RARhLtFJU3RcUztEO-Iyy1gaHW_UHEmW0fdaMpEmOZM4Q130_provenance.
- NP492072.RARhLtFJU3RcUztEO-Iyy1gaHW_UHEmW0fdaMpEmOZM4Q130_assertion wasDerivedFrom befree-20150227 NP492072.RARhLtFJU3RcUztEO-Iyy1gaHW_UHEmW0fdaMpEmOZM4Q130_provenance.
- NP492072.RARhLtFJU3RcUztEO-Iyy1gaHW_UHEmW0fdaMpEmOZM4Q130_assertion wasGeneratedBy ECO_0000203 NP492072.RARhLtFJU3RcUztEO-Iyy1gaHW_UHEmW0fdaMpEmOZM4Q130_provenance.